Article Information
History
- June 23, 2018.
Article Versions
- Version 1 (August 11, 2017 - 13:04).
- You are currently viewing Version 2 of this article (June 23, 2018 - 15:08).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ioanna Pavlaki1,2,
- France Docquier1,3,
- Igor Chernukhin1,4,
- Georgia Kita1,5,
- Svetlana Gretton1,6,
- Christopher T. Clarkson1,
- Vladimir B. Teif1,* and
- Elena Klenova1,*
- 1University of Essex, School of Biological Sciences, Wivenhoe Park, Colchester, Essex CO4 3SQ, UK
- 2Current address: Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
- 3Current address: Department of Medical Genetics, Academic Laboratory of Medical Genetics, University of Cambridge, Box 238, Lv 6 Addenbrooke’s Treatment Centre, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
- 4Current address: Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
- 5Current address: Novartis (Hellas) S.A.C.I., Oncology Medical Affairs, National Road No 1, 12th, 144 51- Metamorphosis, Athens, Greece
- 6Current address: University of Suffolk, Waterfront Building, Neptune Quay, Ipswich, IP4 1QJ, UK.
- ↵*To whom correspondence should be addressed. Tel: (+44) (0)1206-874868; Fax: +44(0)1206872592; Email: klenovae{at}essex.ac.uk or vteif{at}essex.ac.uk